Recombinant interleukin-2-based treatments for advanced melanoma: the experience of the European organization for research and treatment of cancer melanoma cooperative group

U Keilholz; Gerrit Stoter; CJA Punt; C Scheibenbogen; FJ Lejeune; Lex Eggermont

Recombinant interleukin-2-based treatments for advanced melanoma: the experience of the European organization for research and treatment of cancer melanoma cooperative group

U Keilholz, Gerrit Stoter, CJA Punt, C Scheibenbogen, FJ Lejeune, Lex Eggermont

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	22-28
Number of pages	7
Journal	Cancer Journal
Volume	3
Publication status	Published - 1997

Research programs

EMC 04-01-DD-11-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{1874d4949edc486da134f91377dab310,

title = "Recombinant interleukin-2-based treatments for advanced melanoma: the experience of the European organization for research and treatment of cancer melanoma cooperative group",

author = "U Keilholz and Gerrit Stoter and CJA Punt and C Scheibenbogen and FJ Lejeune and Lex Eggermont",

year = "1997",

language = "Undefined/Unknown",

volume = "3",

pages = "22--28",

journal = "Cancer Journal",

issn = "0765-7846",

publisher = "Association Pour le Developpement de la Communication Cancerologique",

}

TY - JOUR

T1 - Recombinant interleukin-2-based treatments for advanced melanoma: the experience of the European organization for research and treatment of cancer melanoma cooperative group

AU - Keilholz, U

AU - Stoter, Gerrit

AU - Punt, CJA

AU - Scheibenbogen, C

AU - Lejeune, FJ

AU - Eggermont, Lex

PY - 1997

Y1 - 1997

M3 - Article

SN - 0765-7846

VL - 3

SP - 22

EP - 28

JO - Cancer Journal

JF - Cancer Journal

ER -